Likewise, the identical SH3 motif of PACSIN2 binds to the proline‐rich domains of SH3BP1, and SH3BP1 overexpression decreases the susceptibility of CML to nilotinib similar to the function of Cobll1. This evidence concerns the gene COBLL1 and chronic myelogenous leukemia, BCR-ABL1 positive.